Drug results: 1

ixazomib an oral proteasome inhibitor with antineoplastic activity; MLN2238 is the biologically active form of MLN9708

Featured News

Drugcentral 2023 NAR Article

The Latest in Chemistry in Coronavirus Research


Drugs in the News


Makena Venetoclax Dapagliflozin KEYTRUDA Sacubitril LORBRENA Hydroxychloroquine


DrugCentral Search Overview